In this file
The weight-management catalog spans different formulations and care pathways. That detail matters when comparing the proposed prescription, payment schedule, and access to help.
This provider file follows the company’s published material and the questions it leaves open. It covers the care arrangement, price, cancellation boundaries, and contact routes; it does not certify the business or determine whether a treatment is appropriate for a particular person.
Understand the care arrangement
Science & Co presents compounded GLP-1 options, branded medicines, and other wellness programs within one catalog. Its process describes an online assessment and clinical review. The patient’s task is to turn that menu into a specific proposal with a named medication and care arrangement.
Name the organizations involved in your own plan. The website operator, clinical practice, and pharmacy may be separate businesses. A patient should know which one is responsible for a medical decision, which holds the account, and which handles the medication.
Read the price in its proper context
The reviewed homepage promotes a first-month percentage discount and a free online evaluation, but it does not establish one total price for every weight-management product. Request the selected medicine’s undiscounted charge, the first invoice, and the recurring payment period. A percentage offer needs an underlying price to be useful.
Record the total paid today, the period it buys, and the next payment. If a figure is expressed per month but collected for several months, keep both numbers in the comparison. Our price-comparison worksheet helps separate a low initial figure from the continuing commitment.
Find the cancellation boundary
Before proceeding, ask how the program renews and how to stop future charges. Clarify whether the free-evaluation wording applies if the clinician does not prescribe and whether a separate medication order has already been authorized. The actual checkout agreement should answer those financial questions.
A useful request names the next renewal and the current order separately. Ask for confirmation of both the effective cancellation date and the pharmacy status. Instructions for stopping or changing the medicine itself need to come from the treating professional.
Identify the actual prescription
The catalog’s compounded and branded entries have different regulatory and formulation questions. A product offered under a familiar drug name should be verified against the prescription and dispensing label. The presence of a brand in a menu is not a guarantee of eligibility, coverage, or stock.
FDA approval concerns a particular drug product. A compounded preparation has not received that approval, and evidence for a different formulation cannot guarantee an individual result. Read the product-approval explanation and ask questions about the exact medicine proposed.
Contact and account help
Science & Co’s published contact number is (844) 587-5747. The documented email route is support@science.co.
Published company support route; use the prescribing professional for treatment decisions.
Start from the official Science & Co website to find its verified patient-account navigation. We have not signed into a private portal or measured its support response. Do not share passwords, access codes, payment-card details, or medical records with a review site.
Bring one concrete question to the consultation
What is the full price before and after the promotion for the exact product the clinician proposes?
Write the answer beside the proposed prescription and agreement. If it describes a different product, an expired promotion, or a plan you are not eligible for, ask for clarification. Our pre-purchase checklist can help keep those questions organized.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- FAQ | Science & Co ↗Provider-published information · Checked September 22, 2026
- Science & Co | Personalized Weight Loss, Longevity & Peptides ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026